Sandoz Shares Fall as Company Turns Cautious on 2026 Sales Guidance
Sandoz cited challenging conditions in Germany and supply constraints for biosimilar drugs in European and international markets.
By Adria CalatayudSandoz Group shares dropped after the company issued a more cautious outlook on top-line growth for 2026, citing challenging conditions in Germany and supply constraints for biosimilar drugs in European and international markets.Shares in the Swiss maker of generic medicines fell…